Tata India Pharma and Healthcare Fund
Direct · Growth ₹40.11
03 Aug 2026
NAV
18.2%
3Y CAGR
19.0%
5Y CAGR
14.0%
10Y CAGR
16.6%
Weighted CAGR
?
Weighted Mean CAGR
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
10.51
Sharpe
-19.8%
Max Drawdown
?
Max Drawdown
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
NA
TER
If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.
| Duration | Invested | Median Value | XIRR | Min XIRR | Max XIRR |
|---|---|---|---|---|---|
| 1 Year | ₹12.00 L | ₹12.41 L | 17.1% | -24.2% | 89.8% |
| 3 Years | ₹36.00 L | ₹46.90 L | 19.6% | -2.5% | 41.5% |
| 5 Years | ₹60.00 L | ₹99.51 L | 21.3% | 12.6% | 31.3% |
| 7 Years | ₹84.00 L | ₹1.77 Cr | 20.5% | 11.9% | 27.8% |
| 10 Years | ₹1.20 Cr | ₹3.08 Cr | 18.1% | 16.4% | 19.4% |
SIP returns vs benchmark & category
Annualised SIP return (XIRR) over each rolling horizon — like-for-like, not lump-sum.
| Duration | Fund SIP XIRR | NIFTY 50 | Category avg | Fund edge |
|---|---|---|---|---|
| 1 Year | 17.1% | 14.5% | 13.9% | +2.6% |
| 3 Years | 19.6% | 11.2% | 16.8% | +8.5% |
| 5 Years | 21.3% | 10.4% | 16.9% | +10.8% |
| 7 Years | 20.5% | 10.6% | 16.6% | +9.9% |
| 10 Years | 18.1% | 11.5% | 16.9% | +6.6% |
| Duration | Mean | Median | Min | Max | Sharpe | Sortino | % Positive | Cat. Mean | Cat. Median |
|---|---|---|---|---|---|---|---|---|---|
| 1 Year | 16.8% | 8.7% | -17.3% | 76.3% | 0.46 | 1.52 | 70% | — | — |
| 3 Years | 18.2% | 21.4% | -3.4% | 30.5% | 1.30 | 4.30 | 91% | — | — |
| 5 Years | 19.0% | 16.9% | 9.3% | 31.6% | 2.32 | — | 100% | — | — |
| 10 Years | 14.0% | 13.8% | 12.6% | 15.3% | 10.51 | — | 100% | — | — |
-19.8%
Max Drawdown
19 mo
Drawdown Duration
13 mo
Recovery Time
-6.1%
Avg Drawdown
Calmar Ratio by Duration
0.84
1Y
0.92
3Y
0.96
5Y
0.91
7Y
0.71
10Y
Compared against NIFTY 50
| Duration | Alpha | Beta | Upside Capture | Downside Capture | Fund CAGR | Bench CAGR |
|---|---|---|---|---|---|---|
| 1 Year | +7.78 | 0.59 | 65.2% | 52.1% | 9.5% | -1.6% |
| 3 Years | +14.22 | 0.59 | 71.4% | 50.8% | 21.2% | 7.3% |
| 5 Years | +7.41 | 0.55 | 61.0% | 48.5% | 15.3% | 8.9% |
| 7 Years | +13.73 | 0.51 | 58.6% | 41.5% | 23.0% | 11.9% |
| 10 Years | +5.82 | 0.54 | 60.5% | 50.6% | 14.7% | 10.9% |
| 12 Years | +3.84 | 0.55 | 60.5% | 51.7% | 12.2% | 9.8% |
| 15 Years | +2.41 | 0.55 | 60.5% | 51.7% | 9.6% | 7.8% |
34
Total Holdings
52.0%
Top 10 Weight
4
Sectors
| # | Stock | % of NAV |
|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LTD | 8.51% |
| 2 | MAX HEALTHCARE INSTITUTE LTD | 5.68% |
| 3 | HEALTHCARE GLOBAL ENTERPRISES LTD | 5.52% |
| 4 | DIVI LABORATORIES LTD | 5.12% |
| 5 | ABBOTT INDIA LTD | 4.97% |
| 6 | CIPLA LTD | 4.77% |
| 7 | APOLLO HOSPITALS ENTERPRISE LTD | 4.61% |
| 8 | RAINBOW CHILDRENS MEDICARE LTD | 4.42% |
| 9 | DR REDDYS LABORATORIES LTD | 4.26% |
| 10 | GLAXOSMITHKLINE PHARMACEUTICALS LTD | 4.12% |